Intoxicating hemp-derived cannabinoids (IHDCs) have become major disruptors in the US’s CBD and legal cannabis sectors for a while now. They include delta-8 THC, delta-10 THC and hexahyrdocannabinol (HHC) to name a few. Despite many believing these would be banned swiftly, many states have in fact chosen to regulate the sale of these cannabinoids – therefore acknowledging their legal status. This report analyses the recent developments of IHDCs in the US, covering a number of states that have addressed their presence on the market.
Reasons to buy
If you are interested in this emergence of IHDCs across the US, then this report provides a comprehensive overview of the current legal status of these cannabinoids in those states that have decided to pass legislation. It offers a detailed summary as well as individual analysis of each state, from those trying to regulate them, to those struggling to regulate them, and those that have implemented an outright ban. It also provides CBD-Intel’s predictions for the future of these cannabinoids in the US.
Table of contents
- Executive summary
- Federal developments
- Summary of IHDC legislative changes by state
- States regulating IHDCs rather than banning
- States struggling to regulate IHDCs
- Another state ban
- Restrictive recreational cannabis states
- The future of IHDCs in the US
The research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including: online and offline resources and data, specialist legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.